Current trend of pneumococcal serotypes distribution and antibiotic susceptibility pattern in Malaysian hospitals

Vaccine

Volumn 29, Issue 34, 2011, Pages 5688-5693

  Rohani, Md Yasin ^a   Zin, Norni Mohd ^a   Hussin, Azura ^b   Nawi, Salbiah Haji ^c   Hanapiah, Suhailah Md ^d   Wahab, Zubaidah Abdul ^e   Raj, Ganeswarie ^f   Shafie, Norazita ^g   Peng, Ng Pey ^h   Chu, Keah K ⁱ   Aziz, Muhhamad Nazri ^j   Maning, Nurahan ^k   Mohamad, Jamilah Said ^l   Benjamin, Adom ^m   Salleh, Mohd Azmi bin Mohd ⁿ   Zahari, Sabarina Sabihah ^o   Francis, Alex ^p   Ahmad, Norazah ^q   Karunakaran, Rina ^r  

^a INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^b Queen Elizabeth Hospital   (Malaysia)

^c Selayang Hospital   (Malaysia)

^d Hospital Tuanku Jaafar   (Malaysia)

^e HOSPITAL SUNGAI BULOH   (Malaysia)

^f HOSPITAL SULTANAH AMINAH   (Malaysia)

^g Hospital Sultanah Nur Zahirah   (Malaysia)

^h Hospital Sultanah Bahiyah   (Malaysia)

ⁱ Tengku Ampuan Rahimah Hospital   (Malaysia)

^j HOSPITAL KUALA LUMPUR   (Malaysia)

^k Hospital Raja Perempuan Zainab II   (Malaysia)

^l Hospital Ampang   (Malaysia)

^m Hospital Umum Sarawak   (Malaysia)

ⁿ HOSPITAL PULAU PINANG   (Malaysia)

^o HOSPITAL RAJA PERMAISURI BAINUN   (Malaysia)

^p Hospital Tengku Ampuan Afzan   (Malaysia)

^q IMR   (Malaysia)

^r UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

more..

Author keywords

Pneumococcal serotype; Pneumococcal susceptibility pattern; Pneumococcal vaccine

Indexed keywords

PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CHILD; COMMUNITY ACQUIRED PNEUMONIA; DISK DIFFUSION; HOSPITAL; HUMAN; MALAYSIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEROTYPE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; MALAYSIA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMONIA; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 79960560805     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.004     Document Type: Article

References (49)

1. Klien J.O., Otitis media. Clin Infect Dis 1994, 19:823-833.
2. Mulholland K. Magnitude of the problem of childhood pneumonia. Lancet 1999, 354:590-592.
3. Schuchat A., Robinson K., Wenger J.D., Harrison L.H., Farley M., Reingold A.L., et al. Bacterial meningitis in the United States in 1995. N Eng J Med 1997, 337(14 (October 2)):970-976.
4. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Lexau C., Reingold A., et al. Increasing prevalence of multidrug resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000, 343(26 (December 28)):1917-1924.
5. Butler J.C., Hoffman J., Cetron M.S., Elliott J.A., Facklam R.R., Breiman R.F. The continued emergence of drug resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinal Surveillance System. J Infect Dis 1996, 174:986-993.
6. Song J.H., Lee N.Y., Ichiyama S., Yoshida R., Hirakata Y., Fu W., et al. Spread of drug resistant Streptococcal pneumoniae in Asian Countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Clin Infect Dis 1999, 28(6 (June)):1206-1211.
7. Cheong Y.M., Jegathesan M., Henrichsen J., Wong Y.H. Antibiotic susceptibility and serotype distribution of S. pneumoniae in Malaysian children. J Trop Pediatr 1988, 34:182-185.
8. Rohani M.Y., Raudzah A., Ng A.J., Ng P.P., Zaidatul A.A., Asmah I., et al. Epidemiology of S. pneumoniae infection in Malaysia. Epidemiol Infect 1999, 122(1 (February)):77-82.
9. Unpublished data from National Surveillance of Antibiotic Resistance. Ministry of Health Malaysia; 2009.
10. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E, et al. Finnish Otitis Media Study Group: efficacy of pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001, 344(6 (February 8)):403-409.
11. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000, 19(3 (March)):187-195.
12. Shapiro E.D., Berg A.T., Austrian R., Schroeder D., Parcells V., Margolis A., et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991, 325(21 (November 21)):1453-1460.
13. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007, 196(9 (November 1)):1346-1354. Epub 2007 (Oct 4).
14. Richter S.S., Heilmann K.P., Dohrn C.L., Riahi F., Beekmann S.E., Doern G.V. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Clin Infect Dis 2009, 48(3 (February 1)):e23-e33.
15. Techasaensiri C., Messina A.F., Katz K., Ahmad N., Huang R., McCracken G.H. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas. Texas Pediatr Infect Dis J 2009, (November 25). Epub ahead of print.
16. Messina A.F., Katz-Gaynor K., Barton T., Ahmad N., Ghaffar F., Rasko D., et al. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J 2007, 26(6 (June)):461-467.
17. Mera R., Miller L.A., Fritsche T.R., Jones R.N. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Microb Drug Resist 2008, 14(2 (June)):101-107.
18. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination. J Infect Dis 2007, 196:1346-1354.
19. Black S., Shinefield H., Baxter R., Austrian R., Elvin L., Hansen J., et al. Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults. Vaccine 2006, 24(Suppl 2):S79-S80.
20. Ruoff K.L., Whiley R.A., Beighton D. Streptococcus. Manual of Clinical Microbiology 2003, 504-521. ASM Press, Washington, D.C., USA. P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken (Eds.).
21. Clinical Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing. Nineteenth informational supplement. 2009; M100-S19, vol. 29. No. 3, Vilanova, PA.
22. Pelton S.I., Huot H., Finkelstein J.A., Bishop C.J., Hsu K.K., Kellenberg J., et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 2007, 26(6 (June)):468-472.
23. Giele C.M., Keil A.D., Lehmann D., Van Buynder P.G. Invasive pneumococcal disease in Western Australia: emergence of serotype 19A. Med J Aust 2009, 190(3):166.
24. Jacobs M.R., Good C.E., Bajaksouzian S., Windau A.R. Emergence of Streptococcus pneumoniae Serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis 2008, 47(11):1388-1395.
25. Choi E.H., Kim S.H., Eun B.W., Kim S.J., Kim N.H., Lee J., Lee H.J. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 2008, 14(2 (February)):275-281.
26. McNeil J.C., Hulten K.G., Mason E.O., Kaplan S.L. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis. Pediatr Infect Dis J 2009, 28(9):766-768.
27. Dagan R. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Infect 2009, 15(Suppl 3 (April)):16-20.
28. Hsu K.K., Shea K.M., Stevenson A.E., Pelton S.I. Members of the Massachusetts department of Public Health. Changing serotypes causing childhood invasive pneumococcal disease: Massachusettes, 2001-2007. Peadiatr Infect Dis J 2009, (November). 10.1097/INF. 0b013e3181c15471.
29. Jacobs M.R., Good C.E., Beall B., Bajaksouzian S., Windau A.R., Whitney C.G. Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumonia strains in Cleveland: a quarter centry of experience. J Clin Microbiol 2008, 46(3 (March)):982-990.
30. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae-Massachusetts, 2001-2006. MMWR Mob Mortal Weekly Report. 2007;56:1077-1080.
31. Srifeungfung S., Tribuddharat C., Comerungsee S., Chatsuwan T., Treerauthanaweeraphong V., Rungnobhakhun P., et al. Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009. Vaccine 2010, 19(April):3440-3444.
32. Soh S.W., Poh C.L., Lin R.V. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from pediatric patients in Singapore. Antimicrob Agents Chemother 2000, 44(8 (August)):2193-2196.
33. Hsu L.-Y., Lui S.W., Lee J.L., Hedzlyn H.M., Kong D.H., Shameen S., et al. Adult invasive pneumococcal disease pre- and peri-pneumococcal conjugate vaccine introduction in a tertiary hospital in Singapore. J Med Microbiol 2009, 58:101-104.
34. Liu Y., Wang H., Chen M., Sun Z., Zhao R., Zhang L., et al. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumonia isolated from children in China younger than 5 years. Diagn Microbiol Infect Dis 2008, 61(3 (July)):256-263.
35. Le Hello S., Watson M., Levy M., Marcon S., Brown M., Yvon J.F., et al. Garin Invasive Serotype 1 Streptococcus pneumoniae Outbreaks in the South Pacific from 2000 to 2007. J Clin Microbiol 2010, 48(8):2968-2971.
36. Leimkugel J., Adams Forgor A., Gagneux S., Pflüger V., Flierl C., Awine E., et al. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis 2005, 192(2):189-191.
37. Atul Gupta F.-M., Khaw E.L., Stokle R.C., George R., Pebody R.E., Stansfield C.L., et al. Outbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school. BMJ 2008, 337:2964.
38. Hausdorff W.P., Bryant J., Paradiso P.R., Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use. Part I. Clin Infect Dis 2000, 30:100-121.
39. Hausdorff W.P., Feikin D.R., Klugman K.P. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005, 5:83-93.
40. Phongsamarta W., Srifeungfunga S., Dejsirilerta S., Chatsuwana T., Nunthapisuda P., Treerauthaweeraphonga V., et al. Serotype distribution and antimicrobial susceptibility of S. pneumoniae causing invasive disease in Thai children younger than 5 years old, 2000-2005. Vaccine 2007, 25:1275-1280.
41. Gordon S.B., Kanyanda S., Walsh A.L., Goddard K. Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi. Emerg Infect Dis 2003, 9(6):747-749.
42. Greenwood B.M., Hassan-King M., Onyemelukwe G., Macfarlane J.T., Tubbs H.R., Tugwell P.J., et al. Pneumococcal serotypes in West Africa. Lancet 1980, 1(8164 (February 16)):360.
43. Hedlund J., Sorberg M., Henriques Normark B., Kronvall G. Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden. Scand J Infect Dis 2003, 35(8):452-458.
44. Melegaro A., Edmunds W.J., Pebody R., Miller E., George R. The current burden of pneumococcal disease in England and Wales. J Infect 2006, 52(1):37-48.
45. Kyaw M.H., Lynfield R., Schaffner W., Craig A.S., Hadler J., Reingold A., et al. Active bacterial core surveillance of the emerging infections program network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006, 354(14):1455-1463.
46. Rohani M.Y., Parasakthi N., Raudzah A., Yasim M.Y. In-vitro susceptibilities of Streptococcus pneumoniae strains isolated in Malaysia to six antibiotics. J Antimicrob Chemother 1999, 44:852-853.
47. Desa M.N., Lin T.K., Yasin R.M., Parasakthi N. Penicillin susceptibility and molecular characteristics of clinical isolates of Streptococcus pneumoniae at the University of Malaya Medical Center Kuala Lumpur Malaysia. Int J Infect Dis 2003, 7(3):190-197.
48. Albrich W.C., Baughman W., Schmotzer B., Farley M.M. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Clin Infect Dis 2007, 44:1569-1576.
49. Normark B.H., Ortqvist A., Kalin M., Olsson-Liljequist B., Hedlund J., Svenson S.B., et al. Changes in serotype distribution may hamper efficacy of pneumococcal conjugate vaccines in children. Scand J Infect Dis 2001, 33(11):848-850.